<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1d3 20150301//EN"  "JATS-archivearticle1.dtd"><article article-type="research-article" dtd-version="1.1d3" xmlns:xlink="http://www.w3.org/1999/xlink"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn publication-format="electronic">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">42276</article-id><article-id pub-id-type="doi">10.7554/eLife.42276</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Biochemistry and Chemical Biology</subject></subj-group><subj-group subj-group-type="heading"><subject>Microbiology and Infectious Disease</subject></subj-group></article-categories><title-group><article-title>Optimization-by-design of hepatotropic lipid nanoparticles targeting the sodium-taurocholate cotransporting polypeptide</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes" id="author-123635"><name><surname>Witzigmann</surname><given-names>Dominik</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="corresp" rid="cor1">*</xref><xref ref-type="other" rid="par-1"/><xref ref-type="other" rid="par-6"/><xref ref-type="other" rid="par-8"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-123636"><name><surname>Uhl</surname><given-names>Philipp</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-123637"><name><surname>Sieber</surname><given-names>Sandro</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="par-6"/><xref ref-type="other" rid="par-7"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-123638"><name><surname>Kaufman</surname><given-names>Christina</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-123639"><name><surname>Einfalt</surname><given-names>Tomaz</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-123640"><name><surname>Schöneweis</surname><given-names>Katrin</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-123641"><name><surname>Grossen</surname><given-names>Philip</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-3416-5570</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-123648"><name><surname>Buck</surname><given-names>Jonas</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="par-2"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-123642"><name><surname>Ni</surname><given-names>Yi</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-123643"><name><surname>Schenk</surname><given-names>Susanne H</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-123644"><name><surname>Hussner</surname><given-names>Janine</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-123645"><name><surname>Meyer zu Schwabedissen</surname><given-names>Henriette E</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-0458-4579</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-123646"><name><surname>Québatte</surname><given-names>Gabriela</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-123647"><name><surname>Mier</surname><given-names>Walter</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-24257"><name><surname>Urban</surname><given-names>Stephan</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="other" rid="par-3"/><xref ref-type="other" rid="par-4"/><xref ref-type="other" rid="par-5"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-121775"><name><surname>Huwyler</surname><given-names>Jörg</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-1748-5676</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="corresp" rid="cor2">*</xref><xref ref-type="other" rid="par-2"/><xref ref-type="other" rid="par-6"/><xref ref-type="fn" rid="conf1"/></contrib><aff id="aff1"><institution content-type="dept">Department of Pharmaceutical Sciences</institution>, <institution>University of Basel</institution>, <addr-line><named-content content-type="city">Basel</named-content></addr-line>, <country>Switzerland</country></aff><aff id="aff2"><institution content-type="dept">Department of Nuclear Medicine</institution>, <institution>University Hospital Heidelberg</institution>, <addr-line><named-content content-type="city">Heidelberg</named-content></addr-line>, <country>Germany</country></aff><aff id="aff3"><institution content-type="dept">Department of Infectious Diseases</institution>, <institution>University Hospital Heidelberg</institution>, <addr-line><named-content content-type="city">Heidelberg</named-content></addr-line>, <country>Germany</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor" id="author-56267"><name><surname>Kana</surname><given-names>Bavesh D</given-names></name><role>Reviewing editor</role><aff><institution>University of the Witwatersrand</institution>, <country>South Africa</country></aff></contrib></contrib-group><author-notes><corresp id="cor1"><label>*</label>For correspondence: <email>dominik.witzigmann@unibas.ch</email> (DW);</corresp><corresp id="cor2"><label>*</label>For correspondence: <email>joerg.huwyler@unibas.ch</email> (JH);</corresp></author-notes><pub-date date-type="pub" publication-format="electronic"><day>23</day><month>07</month><year>2019</year></pub-date><volume>8</volume><elocation-id>e42276</elocation-id><history><date date-type="received"><day>24</day><month>09</month><year>2018</year></date><date date-type="accepted"><day>17</day><month>07</month><year>2019</year></date></history><permissions><copyright-statement>© 2019, Witzigmann et al</copyright-statement><copyright-year>2019</copyright-year><copyright-holder>Witzigmann et al</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link> permitting unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-42276-v1.pdf"/><abstract><p>Active targeting and specific drug delivery to parenchymal liver cells is a promising strategy to treat various liver disorders. Here, we modified synthetic lipid-based nanoparticles with targeting peptides derived from the hepatitis B virus large envelope protein (HBVpreS) to specifically target the sodium-taurocholate cotransporting polypeptide (NTCP; <italic>SLC10A1</italic>) on the sinusoidal membrane of hepatocytes. Physicochemical properties of targeted nanoparticles were optimized and NTCP-specific, ligand-dependent binding and internalization was confirmed <italic>in vitro</italic>. The pharmacokinetics and targeting capacity of selected lead formulations was investigated <italic>in vivo</italic> using the emerging zebrafish screening model. Liposomal nanoparticles modified with 0.25 mol% of a short myristoylated HBV derived peptide, <italic>i.e.</italic> Myr‑HBVpreS2-31, showed an optimal balance between systemic circulation, avoidance of blood clearance, and targeting capacity. Pronounced liver enrichment, active NTCP‑mediated targeting of hepatocytes and efficient cellular internalization were confirmed in mice by <sup>111</sup>In gamma scintigraphy and fluorescence microscopy demonstrating the potential use of our hepatotropic, ligand-modified nanoparticles.</p></abstract><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Mouse</kwd><kwd>Rat</kwd><kwd>Zebrafish</kwd></kwd-group><funding-group><award-group id="par-1"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100001711</institution-id><institution>Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung</institution></institution-wrap></funding-source><award-id>174975</award-id><principal-award-recipient><name><surname>Witzigmann</surname><given-names>Dominik</given-names></name></principal-award-recipient></award-group><award-group id="par-2"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100001711</institution-id><institution>Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung</institution></institution-wrap></funding-source><award-id>173057</award-id><principal-award-recipient><name><surname>Buck</surname><given-names>Jonas</given-names></name><name><surname>Huwyler</surname><given-names>Jörg</given-names></name></principal-award-recipient></award-group><award-group id="par-3"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100001659</institution-id><institution>Deutsche Forschungsgemeinschaft</institution></institution-wrap></funding-source><award-id>209091148</award-id><principal-award-recipient><name><surname>Urban</surname><given-names>Stephan</given-names></name></principal-award-recipient></award-group><award-group id="par-4"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100009139</institution-id><institution>Deutsches Zentrum für Infektionsforschung</institution></institution-wrap></funding-source><award-id>5.704</award-id><principal-award-recipient><name><surname>Urban</surname><given-names>Stephan</given-names></name></principal-award-recipient></award-group><award-group id="par-5"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100009139</institution-id><institution>Deutsches Zentrum für Infektionsforschung</institution></institution-wrap></funding-source><award-id>5.807</award-id><principal-award-recipient><name><surname>Urban</surname><given-names>Stephan</given-names></name></principal-award-recipient></award-group><award-group id="par-6"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100009736</institution-id><institution>Freiwillige Akademische Gesellschaft</institution></institution-wrap></funding-source><award-id>FAG Basel</award-id><principal-award-recipient><name><surname>Witzigmann</surname><given-names>Dominik</given-names></name><name><surname>Sieber</surname><given-names>Sandro</given-names></name><name><surname>Huwyler</surname><given-names>Jörg</given-names></name></principal-award-recipient></award-group><award-group id="par-7"><funding-source><institution-wrap><institution>Stiftung zur Förderung des pharmazeutischen Nachwuchses in Basel</institution></institution-wrap></funding-source><principal-award-recipient><name><surname>Sieber</surname><given-names>Sandro</given-names></name></principal-award-recipient></award-group><award-group id="par-8"><funding-source><institution-wrap><institution>Novartis University Basel Excellence SCholarship for Life Sciences</institution></institution-wrap></funding-source><principal-award-recipient><name><surname>Witzigmann</surname><given-names>Dominik</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group></article-meta></front><back><sec id="s1" sec-type="additional-information"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interest</title><fn fn-type="conflict" id="conf1"><p>The authors declare that no competing interests exist.</p></fn></fn-group><fn-group content-type="ethics-information"><title>Ethics</title><fn fn-type="other"><p>Animal experimentation: Animal experimentation: Zebrafish embryo (Danio rerio) studies were performed in strict accordance with Swiss animal welfare regulations. Mouse and rat experiments were carried out in accordance with German legislation on animal welfare. All of the animals were handled according to approved institutional animal care and use protocol of the University of Basel and University of Heidelberg.</p></fn></fn-group></sec><sec id="s2" sec-type="supplementary-material"><title>Additional Files</title><sec id="s3" sec-type="data-availability"><title>Data availability</title><p>All data generated or analysed during this study are included in the manuscript and supporting files. Numerical data for all quantitative graphs are provided in the Figure source data.</p></sec><supplementary-material><ext-link xlink:href="elife-42276-supp-v1.zip">Download zip</ext-link><p>Any figures and tables for this article are included in the PDF. The zip folder contains additional supplemental files.</p></supplementary-material></sec></back></article>